Exelixis Inc Interest Income, Other
Exelixis Inc (EXEL) reported Interest Income, Other of $14.21 million for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2026-08-05
- Exelixis Inc interest income, other for the quarter ending 2026-07-03 was $14.21M, a 15.36% decline year-over-year.
- Exelixis Inc interest income, other for the quarter ending 2026-04-03 was $16.13M, a 15.46% decline year-over-year.
- Exelixis Inc interest income, other for the quarter ending 2026-01-02 was $17.43M, a 18.17% decline year-over-year.
- Exelixis Inc interest income, other for the quarter ending 2025-10-03 was $15.92M, a 14.90% decline year-over-year.
- Exelixis Inc interest income, other for fiscal 2026 was $69.21M, a 10.29% decline from fiscal 2025.
- Exelixis Inc interest income, other for fiscal 2025 was $77.16M, a 10.85% decline from fiscal 2023.
- Exelixis Inc interest income, other for fiscal 2023 was $86.54M, a 161.74% increase from fiscal 2022.
- Exelixis Inc interest income, other for fiscal 2022 was $33.06M, a 330.98% increase from fiscal 2021.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month |
|---|---|---|---|---|
| 2026-07-03 | $14.21M 10-Q · filed 2026-08-05 | $30.34M 10-Q · filed 2026-08-05 | $47.76M derived: sum of 3 quarters · filed 2026-08-05 | $63.69M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-04-03 | $16.13M 10-Q · filed 2026-05-05 | $33.55M derived: sum of 2 quarters · filed 2026-05-05 | $49.48M derived: sum of 3 quarters · filed 2026-05-05 | $66.26M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-01-02 | $17.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $33.35M derived: sum of 2 quarters · filed 2026-02-10 | $50.14M derived: sum of 3 quarters · filed 2026-08-05 | $69.21M 10-K · filed 2026-02-10 |
| 2025-10-03 | $15.92M 10-Q · filed 2025-11-04 | $32.71M derived: sum of 2 quarters · filed 2026-08-05 | $51.79M 10-Q · filed 2025-11-04 | $73.08M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-07-04 | $16.79M 10-Q · filed 2026-08-05 | $35.87M 10-Q · filed 2026-08-05 | $57.16M derived: sum of 3 quarters · filed 2026-08-05 | $75.87M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-04-04 | $19.08M 10-Q · filed 2026-05-05 | $40.37M derived: sum of 2 quarters · filed 2026-05-05 | $59.08M derived: sum of 3 quarters · filed 2026-05-05 | $76.34M derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-01-03 | $21.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $40.00M derived: sum of 2 quarters · filed 2026-02-10 | $57.26M derived: sum of 3 quarters · filed 2026-02-10 | $77.16M 10-K · filed 2026-02-10 |
| 2024-09-27 | $18.71M 10-Q · filed 2025-11-04 | $35.97M derived: sum of 2 quarters · filed 2025-11-04 | $55.86M 10-Q · filed 2025-11-04 | $77.25M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-28 | $17.26M 10-Q · filed 2025-07-28 | $37.15M 10-Q · filed 2025-07-28 | $58.54M derived: sum of 3 quarters · filed 2026-02-10 | $81.65M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-29 | $19.89M 10-Q · filed 2025-05-13 | $41.28M derived: sum of 2 quarters · filed 2026-02-10 | $64.39M derived: sum of 3 quarters · filed 2026-02-10 | $86.94M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-29 | $21.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $44.50M derived: sum of 2 quarters · filed 2026-02-10 | $67.04M derived: sum of 3 quarters · filed 2026-02-10 | $86.54M 10-K · filed 2026-02-10 |
| 2023-09-29 | $23.11M 10-Q · filed 2024-10-29 | $45.65M derived: sum of 2 quarters · filed 2024-10-29 | $65.16M 10-Q · filed 2024-10-29 | $82.14M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | $22.54M 10-Q · filed 2024-08-06 | $42.04M 10-Q · filed 2024-08-06 | $59.03M derived: sum of 3 quarters · filed 2025-02-11 | $68.53M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | $19.50M 10-Q · filed 2024-04-30 | $36.49M derived: sum of 2 quarters · filed 2025-02-11 | $45.99M derived: sum of 3 quarters · filed 2025-02-11 | $50.74M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-30 | $16.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $26.49M derived: sum of 2 quarters · filed 2025-02-11 | $31.24M derived: sum of 3 quarters · filed 2025-02-11 | $33.06M 10-K · filed 2025-02-11 |
| 2022-09-30 | $9.50M 10-Q · filed 2023-11-01 | $14.26M derived: sum of 2 quarters · filed 2023-11-01 | $16.08M 10-Q · filed 2023-11-01 | $17.52M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-07-01 | $4.76M 10-Q · filed 2023-08-01 | $6.58M 10-Q · filed 2023-08-01 | $8.02M derived: sum of 3 quarters · filed 2024-02-06 | $9.68M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-04-01 | $1.82M 10-Q · filed 2023-05-09 | $3.26M derived: sum of 2 quarters · filed 2024-02-06 | $4.92M derived: sum of 3 quarters · filed 2024-02-06 | $6.81M derived: sum of 4 quarters · filed 2024-02-06 |
| 2021-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-06 | $3.10M derived: sum of 2 quarters · filed 2024-02-06 | $4.99M derived: sum of 3 quarters · filed 2024-02-06 | $7.67M 10-K · filed 2024-02-06 |
| 2021-10-01 | $1.66M 10-Q · filed 2022-11-01 | $3.55M derived: sum of 2 quarters · filed 2022-11-01 | $6.23M 10-Q · filed 2022-11-01 | $9.72M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-07-02 | $1.89M 10-Q · filed 2022-08-09 | $4.57M 10-Q · filed 2022-08-09 | $8.06M derived: sum of 3 quarters · filed 2023-02-07 | $12.06M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-04-02 | $2.68M 10-Q · filed 2022-05-10 | $6.17M derived: sum of 2 quarters · filed 2023-02-07 | $10.16M derived: sum of 3 quarters · filed 2023-02-07 | $15.33M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-01-01 | $3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $7.48M derived: sum of 2 quarters · filed 2023-02-07 | $12.64M derived: sum of 3 quarters · filed 2023-02-07 | $19.86M 10-K · filed 2023-02-07 |
| 2020-10-02 | $3.99M 10-Q · filed 2021-11-02 | $9.16M derived: sum of 2 quarters · filed 2021-11-02 | $16.38M 10-Q · filed 2021-11-02 | $24.08M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-07-03 | $5.16M 10-Q · filed 2021-08-05 | $12.38M 10-Q · filed 2021-08-05 | $20.09M derived: sum of 3 quarters · filed 2022-02-18 | $27.28M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-04-03 | $7.22M 10-Q · filed 2021-05-06 | $14.93M derived: sum of 2 quarters · filed 2022-02-18 | $22.12M derived: sum of 3 quarters · filed 2022-02-18 | $29.09M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-01-03 | $7.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $14.90M derived: sum of 2 quarters · filed 2022-02-18 | $21.87M derived: sum of 3 quarters · filed 2022-02-18 | $27.96M 10-K · filed 2022-02-18 |
| 2019-09-27 | $7.19M 10-Q · filed 2020-11-05 | $14.17M derived: sum of 2 quarters · filed 2020-11-05 | $20.25M 10-Q · filed 2020-11-05 | $24.99M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-28 | $6.97M 10-Q · filed 2020-08-06 | $13.06M 10-Q · filed 2020-08-06 | $17.80M derived: sum of 3 quarters · filed 2020-08-06 | $21.31M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-29 | $6.09M 10-Q · filed 2020-05-05 | $10.83M derived: sum of 2 quarters · filed 2020-05-05 | $14.34M derived: sum of 3 quarters · filed 2020-05-05 | $17.03M derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-28 | $4.74M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $8.25M derived: sum of 2 quarters · filed 2020-02-25 | $10.95M derived: sum of 3 quarters · filed 2020-02-25 | $12.84M 10-K · filed 2021-02-11 |
| 2018-09-28 | $3.51M 10-Q · filed 2019-10-30 | $6.20M derived: sum of 2 quarters · filed 2019-10-30 | $8.10M 10-Q · filed 2019-10-30 | $9.48M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-29 | $2.70M 10-Q · filed 2019-07-31 | $4.59M 10-Q · filed 2019-07-31 | $5.98M derived: sum of 3 quarters · filed 2020-02-25 | $7.11M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-30 | $1.90M 10-Q · filed 2019-05-01 | $3.28M derived: sum of 2 quarters · filed 2020-02-25 | $4.41M derived: sum of 3 quarters · filed 2020-02-25 | $5.67M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-29 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $2.52M derived: sum of 2 quarters · filed 2020-02-25 | $3.77M derived: sum of 3 quarters · filed 2020-02-25 | $4.88M 10-K · filed 2020-02-25 |
| 2017-09-29 | $1.13M 10-Q · filed 2018-11-01 | $2.38M derived: sum of 2 quarters · filed 2018-11-01 | $3.50M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $1.25M 10-Q · filed 2018-08-01 | $2.36M 10-Q · filed 2018-08-01 | ||
| 2017-03-31 | $1.11M 10-Q · filed 2018-05-02 | |||
| 2016-12-30 | $2.58M 10-K · filed 2019-02-22 | |||
| 2016-01-01 | $793.00K 10-K · filed 2018-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |